InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AHJ | Ann: Removal from Official List | 04/01/16 | 0 | 259 | |||
|
|||||||
AHJ | Ann: Air Change to list on the NSX | 15/12/15 | 0 | 378 | |||
|
|||||||
AHJ | Ann: Results of Meeting | 23/11/15 | 0 | 194 | |||
|
|||||||
AHJ | Ann: Chairman's Address to Shareholders | 23/11/15 | 0 | 179 | |||
|
|||||||
AHJ | Ann: Appendix 4C - quarterly | 28/10/15 | 0 | 175 | |||
|
|||||||
AHJ | Ann: Notice of Annual General Meeting/Proxy Form | 26/10/15 | 0 | 127 | |||
|
|||||||
AHJ | Ann: Full Year Statutory Accounts | 26/08/15 | 0 | 193 | |||
|
|||||||
AHJ | Ann: Preliminary Final Report | 26/08/15 | 0 | 157 | |||
|
See All Discussions